Hemophilia A and B Recombinant Factor Replacement Therapy Market Report

Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 11, 2022
  • PAGES：191
  • REPORT CODE：GMM1456234
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptoms include bleeding from any site of the body. Internal bleeding is fatal as internal bleeding inside the joint causes joint damage and inside the brain, causes brain damage and seizers. The disease is inherited in an X-linked recessive genetic pattern, therefore males are commonly affected with haemophilia while females are usually carriers of the disease. Haemophilia A is caused by the deficiency of clotting Factor VIII, whereas haemophilia B is caused by the deficiency of Factor IX. It is also known as Christmas disease. The disease management includes factor replacement therapy. Factor replacement therapy is the infusion of factor VIII and IX concentrates through injection to control bleeding. These factor concentrates come from two sources i.e. from human plasma or from genetically engineered cell line made by recombinant DNA technology.

    This report elaborates on the current development of the Hemophilia A and B Recombinant Factor Replacement Therapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Novo Nordisk

    • Baxalta

    • Spark therapeutics

    • Pfizer

    • Biogen

    • Uniqure

    • Bayer

    • CSL Behring

    • Emergent Biosolutions

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Haemophilia A

    • Haemophilia B

    Application:

    • Hospitals

    • Clinics

    • Ambulatory Surgical Centers

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Overview

      • 1.1.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Scope and Market Segments

      • 1.1.2 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Characteristics

      • 1.1.3 Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Production Value and Growth Rate (2017-2028)

    • 1.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Haemophilia A

      • 1.2.2 Haemophilia B

    • 1.3 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Ambulatory Surgical Centers

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Hemophilia A and B Recombinant Factor Replacement Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Porter's Five Forces Model Analysis

      • 2.2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Industry PEST Analysis

    • 2.3 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Hemophilia A and B Recombinant Factor Replacement Therapy Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Hemophilia A and B Recombinant Factor Replacement Therapy Industry

    Chapter 3 Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Manufacturer

    • 3.1 Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Market Top 3 Players

    Chapter 4 Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Type (2017-2028)

    • 4.1 Hemophilia A and B Recombinant Factor Replacement Therapy Market Trend, by Type

    • 4.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Hemophilia A and B Recombinant Factor Replacement Therapy Price Trend, by Type (2017-2028)

    • 4.3 China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Hemophilia A and B Recombinant Factor Replacement Therapy Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Analysis

    • 7.1 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Type

    • 7.2 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Application

    • 7.3 North America Hemophilia A and B Recombinant Factor Replacement Therapy Market Analysis and Forecast, by Country

      • 7.3.1 United States Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Analysis

    • 8.1 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Type

    • 8.2 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Application

    • 8.3 Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Analysis and Forecast, by Country

      • 8.3.1 Germany Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Analysis

    • 9.1 APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Type

    • 9.2 APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Application

    • 9.3 APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Analysis and Forecast, by Country

      • 9.3.1 China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Analysis

    • 10.1 Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Type

    • 10.2 Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market, by Application

    • 10.3 Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Company Profiles

      • 11.1 Novo Nordisk

        • 11.1.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Product Profiles, Application and Specification

        • 11.1.3 Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Baxalta

        • 11.2.1 Baxalta Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Product Profiles, Application and Specification

        • 11.2.3 Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Spark therapeutics

        • 11.3.1 Spark therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Product Profiles, Application and Specification

        • 11.3.3 Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Pfizer

        • 11.4.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Product Profiles, Application and Specification

        • 11.4.3 Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Biogen

        • 11.5.1 Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Product Profiles, Application and Specification

        • 11.5.3 Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Uniqure

        • 11.6.1 Uniqure Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Product Profiles, Application and Specification

        • 11.6.3 Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Bayer

        • 11.7.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Product Profiles, Application and Specification

        • 11.7.3 Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 CSL Behring

        • 11.8.1 CSL Behring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Product Profiles, Application and Specification

        • 11.8.3 CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Emergent Biosolutions

        • 11.9.1 Emergent Biosolutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Product Profiles, Application and Specification

        • 11.9.3 Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Investment Prospect and Risk Assessment

    • 12.1 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Hemophilia A and B Recombinant Factor Replacement Therapy Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Production Value and Growth Rate (2017-2028)

    • Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Production Value and Growth Rate (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size and Growth Rate of Haemophilia A (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size and Growth Rate of Haemophilia B (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size and Growth Rate of Ambulatory Surgical Centers (2017-2028)

    • Figure North America Hemophilia A and B Recombinant Factor Replacement Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Hemophilia A and B Recombinant Factor Replacement Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Hemophilia A and B Recombinant Factor Replacement Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Market Share, by Manufacturer in 2021

    • Figure Global and China Hemophilia A and B Recombinant Factor Replacement Therapy Market Share, by Manufacturer in 2022

    • Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Type (2017-2028)

    • Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value, by Type (2017-2028)

    • Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value Share, by Type (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Price Trend, by Type (2017-2028)

    • Table China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Type (2017-2028)

    • Table China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Table China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value, by Type (2017-2028)

    • Table China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value Share, by Type (2017-2028)

    • Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Price Trend, by Type (2017-2028)

    • Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Application (2017-2028)

    • Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value, by Application (2017-2028)

    • Table Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value Share, by Application (2017-2028)

    • Figure Global Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value Share, by Application (2017-2028)

    • Table China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Application (2017-2028)

    • Table China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Table China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value, by Application (2017-2028)

    • Table China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value Share, by Application (2017-2028)

    • Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value Share, by Application (2017-2028)

    • Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure North America Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Production, Import, Consumption and Export (2017-2022)

    • Table North America Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Type (2017-2028)

    • Table North America Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Figure North America Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Table North America Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Application (2017-2028)

    • Table North America Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Figure North America Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Figure United States Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure United States Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Canada Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Table Europe Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Type (2017-2028)

    • Table Europe Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Europe Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Table Europe Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Application (2017-2028)

    • Table Europe Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Europe Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Germany Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure UK Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure UK Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure France Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure France Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Italy Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Spain Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Poland Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Russia Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Table APAC Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Type (2017-2028)

    • Table APAC Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Figure APAC Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Table APAC Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Application (2017-2028)

    • Table APAC Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Figure APAC Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure China Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Japan Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure India Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure India Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Hemophilia A and B Recombinant Factor Replacement Therapy Sales Value and Growth Rate (2017-2028)

    • Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novo Nordisk Product Profiles, Application and Specification

    • Table Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Baxalta Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Baxalta Product Profiles, Application and Specification

    • Table Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Spark therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Spark therapeutics Product Profiles, Application and Specification

    • Table Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biogen Product Profiles, Application and Specification

    • Table Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Uniqure Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Uniqure Product Profiles, Application and Specification

    • Table Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CSL Behring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CSL Behring Product Profiles, Application and Specification

    • Table CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Emergent Biosolutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Emergent Biosolutions Product Profiles, Application and Specification

    • Table Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US